Page 45 of pharmaceuticals

Lupin, Lupin Limited, HIV/AIDS, drugs, generic drugs, healthcare news, pharma news,

Lupin launches generic tablets for mental disorders in United States

Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg (RLD Latuda) had estimated annual sales…

February 21, 2023 14:46 IST

GlobalData, Rare Diseases, China market, healthcare news, pharma news,

USFDA tentatively approves Zydus’ tablets for seizures treatment

According to data by IQVIA MAT in December 2022, Gabapentin Tablets had annual sales of USD 90 million in the…

February 21, 2023 14:20 IST

Glenmark Pharmaceuticals, glenmark pharma, healthcare news, pharma news,

Glenmark Pharmaceuticals receives second ANDA tentative approval for blood-sugar-lowering tablets

Glenmark’s first tentative approval letter for Saxagliptin Tablets, 2.5 mg, and 5 mg was received on June 12, 2017.

February 19, 2023 13:29 IST

AstraZeneca, AstraZeneca pharma, breast cancer, healthcare news, pharma news,

AstraZeneca’s drug receives CDSCO approval in India for Biliary Tract Cancer

Studies show that early-stage BTC often presents without clear symptoms and most new cases of BTC are therefore diagnosed at…

February 17, 2023 20:25 IST

Novo Nordisk, Novo Nordisk India, Insulin, diabetes, healthcare news,

FE Exclusive | There is still a lot of untapped opportunities in India’s diabetes market: John Dawber, Global Business Head, Novo Nordisk

John Dawber told Financial Express.com that other than focusing on insulin they will continue to work on innovative solutions for…

February 16, 2023 22:30 IST

Novo Nordisk, Novo Nordisk India, Healthcare News, Pharma news,

Pharma major Novo Nordisk completes 100 years; Hopes to advance further in diabetic care in coming years

On this occasion, the company launched a digital employee community outreach portal aimed at encouraging employees to volunteer for community…

February 16, 2023 15:53 IST

Glenmark Pharma reports revenue growth of 9.2 percent, PAT of 21.3 percent YoY in Q3FY23

Meanwhile, consolidated profit before tax jumped 37.3% to Rs 471 crore in Q3 FY23 from Rs 343.04 crore in Q3…

February 14, 2023 12:11 IST

Artificial Intelligence, AI, healthcare, healthtech, low-cost drugs, healthcare news,

Artificial intelligence facilitates low-cost drug repurposing: GlobalData

In January this year, US-based companies Medable and Every Cure partnered to use drug repurposing to accelerate the discovery of…

February 10, 2023 17:34 IST

Lupin, Lupin Limited, Vizag, EIR, healthcare news, pharma news,

Lupin reports decline in profit by 72 percent to Rs. 153 crore in Q3FY23

The consolidated revenue advanced albeit marginally by 3.9 percent year-on-year (YoY) to Rs 4,322 crore in Q3FY23.

February 10, 2023 15:25 IST

Drug Prices, Diabetes, Anxiety, NPPA, healthcare news, pharma news,

IOL Chemicals and Pharmaceuticals’ net profit declines 39.73 percent in December 2022 quarter

Sales declined 5.70% to Rs 523.48 crore in the quarter ended December 2022 as against Rs 555.14 crore during the…

February 8, 2023 15:46 IST

Obesity, Obesity drugs, semaglutide, cancer, cancer treatment, cancer research, healthcare news, pharma news,

Olezarsen’s fast track FDA approval strengthens Ionis Pharmaceuticals outlook in cholesterol disorder space: GlobalData

According to GlobalData, Waylivra (volanesorsen) is another apoCII inhibitor marketed by Ionis in the EU for patients with FCS with…

February 8, 2023 15:31 IST

diabetes, obesity, screening, healthcare news, healthtech news,

Akums Pharma gets DCGI approval to launch drug for type 2 diabetic patients

The number of people with diabetes in India is the second highest in the world (74 million), after China (141…

February 6, 2023 14:21 IST

USFDA accepts Sandoz’ Biologics License Application for proposed osteoporosis drug biosimilar

According to the pharma major, it is predicted that one in two of these women and one in four men…

February 6, 2023 13:09 IST

Rare Diseases, healthcare, healthcare news, health news,

Zynerba’s drug could target genetic condition that causes developmental problems but likely to face barrier in uptake: GlobalData

Zygel is anticipated to launch in the US in Q3 2025 and is forecast to generate US sales of $17.9…

February 3, 2023 16:36 IST

Sun Pharma, Q3FY22, quarterly results, Sun pharma results, healthcare news, pharma news,

Sun Pharma reports rise in net profit by 5 percent to Rs. 2,166 crore yoy in Q3FY22

Earlier, Sun Pharma had paid interim dividend of ₹7 per share for the previous financial year 2021-22.

January 31, 2023 14:47 IST

USFDA tentatively approves Lupin’s HIV/AIDS tablets

The tentative approval has been granted under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

January 31, 2023 14:25 IST

Sun Pharma, fourth quarter, Q4FY23 results, profit, revenue, dividend

Sun Pharma acquires three brands from Aksigen to strengthen its anti-inflammatory portfolio

According to IQVIA data MAT Nov 2022, India’s overall market of proteolytic enzyme for healing, pain and edema is around…

January 30, 2023 13:00 IST

Alkem, BDR Pharma launch antibiotics for multiple drug-resistant infections in India

The pharma company claims that Zidavi (ceftazidime-avibactam) is a potential therapeutic option for the treatment of infections complicated by multi-drug…

January 30, 2023 12:20 IST

Related News

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Tata Capital IPO share price today, October 13

LIVE: Tata Capital lists at 1.23% premium; JM Financial predicts 10% upside in 12 months

Sminu Jindal criticised IndiGo for its careless handling of her custom-built wheelchair, adding that it is not “just equipment”, but a symbol of “mobility, independence, and dignity”.

‘What happened with my daughter is deeply concerning,’ Naveen Jindal slams IndiGo over wheelchair incident

Doshi siblings enter Forbes India Rich List 2025.

India’s newest billionaire siblings: How a solar IPO powered four brothers onto Forbes 2025 Rich List for the first time

Google manager quits Rs 3.4 crore job, says ‘the work was pleasant, but…’

Who is Mira Murati? ‘Mother of ChatGPT’ Zuckerberg failed to poach

Trending News34 min ago

Meta CEO Mark Zuckerberg is leading one of the fiercest recruiting drives in Silicon Valley history. Zuckerberg has been on a mission to build an AI “dream team,” poaching leaders from Anthropic, Google DeepMind, Apple, and even OpenAI.

View all shorts